Historical record - last NADAC effective date: 7/19/2017
Product Information
OMEPRAZOLE DR 10 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2241 per EA under NDC 68382041106. Its NADAC has been published 193 times since Nov 28, 2013.
FDA first approved this application on Nov 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382041106
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
7/19/2017
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091352FDA Approved
11/19/2012
TE Code
AB
On Market Since
11/23/2012
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 10 MG CAPSULE has been published 193 times since Nov 28, 2013, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2241 per EA |
|---|---|
| All-time high | $0.3247 (Sep 16, 2015) |
| All-time low | $0.2241 (Jul 19, 2017) |
| Median price | $0.2701 |
| Average price | $0.2723 |
| Largest weekly change | +36.5% (Apr 19, 2017) |
| Weeks tracked | 193 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.9%
Last surveyed Aug 2, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 10 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2241 per EA (NDC 68382041106), effective Aug 2, 2017.
How has the price of OMEPRAZOLE DR 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 10 MG CAPSULE has declined 9.9%. It has been tracked across 193 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 10 MG CAPSULE?
Since Nov 28, 2013, the NADAC for OMEPRAZOLE DR 10 MG CAPSULE has ranged from a low of $0.2241 (Jul 19, 2017) to a high of $0.3247 (Sep 16, 2015), with a median of $0.2701 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 10 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 10 MG CAPSULE, is $0.0680 per EA — about 70% below OMEPRAZOLE DR 10 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 10 MG CAPSULE?
OMEPRAZOLE DR 10 MG CAPSULE (NDC 68382041106) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.